Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 3.60
SSH's Cash to Debt is ranked higher than
55% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SSH: 3.60 )
Ranked among companies with meaningful Cash to Debt only.
SSH' s Cash to Debt Range Over the Past 10 Years
Min: 3.6  Med: 10000.00 Max: No Debt
Current: 3.6
F-Score: 2
Z-Score: -7.98
M-Score: -99999999.99
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -8901.69
SSH's Operating margin (%) is ranked lower than
97% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. SSH: -8901.69 )
Ranked among companies with meaningful Operating margin (%) only.
SSH' s Operating margin (%) Range Over the Past 10 Years
Min: -38764.41  Med: -1906.43 Max: -358.24
Current: -8901.69
-38764.41
-358.24
Net-margin (%) -9058.31
SSH's Net-margin (%) is ranked lower than
97% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SSH: -9058.31 )
Ranked among companies with meaningful Net-margin (%) only.
SSH' s Net-margin (%) Range Over the Past 10 Years
Min: -36877.97  Med: -1906.43 Max: -358.24
Current: -9058.31
-36877.97
-358.24
ROE (%) -97.31
SSH's ROE (%) is ranked lower than
90% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. SSH: -97.31 )
Ranked among companies with meaningful ROE (%) only.
SSH' s ROE (%) Range Over the Past 10 Years
Min: -238.68  Med: -115.44 Max: -63.22
Current: -97.31
-238.68
-63.22
ROA (%) -77.12
SSH's ROA (%) is ranked lower than
88% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. SSH: -77.12 )
Ranked among companies with meaningful ROA (%) only.
SSH' s ROA (%) Range Over the Past 10 Years
Min: -216.94  Med: -110.93 Max: -58.42
Current: -77.12
-216.94
-58.42
ROC (Joel Greenblatt) (%) -4234.12
SSH's ROC (Joel Greenblatt) (%) is ranked lower than
93% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. SSH: -4234.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SSH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4851.22  Med: -3045.01 Max: -774.91
Current: -4234.12
-4851.22
-774.91
EBITDA Growth (3Y)(%) 432.50
SSH's EBITDA Growth (3Y)(%) is ranked higher than
99% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. SSH: 432.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SSH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -20.60 Max: 462.5
Current: 432.5
0
462.5
EPS Growth (3Y)(%) 365.60
SSH's EPS Growth (3Y)(%) is ranked higher than
98% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SSH: 365.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SSH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -17.90 Max: 422.3
Current: 365.6
0
422.3
» SSH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with SSH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.99
SSH's P/B is ranked higher than
83% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. SSH: 0.99 )
Ranked among companies with meaningful P/B only.
SSH' s P/B Range Over the Past 10 Years
Min: 0.99  Med: 2.52 Max: 3.34
Current: 0.99
0.99
3.34
P/S 75.32
SSH's P/S is ranked lower than
99.99% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.31 vs. SSH: 75.32 )
Ranked among companies with meaningful P/S only.
SSH' s P/S Range Over the Past 10 Years
Min: 75.32  Med: 340.00 Max: 575
Current: 75.32
75.32
575
Current Ratio 4.74
SSH's Current Ratio is ranked higher than
74% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. SSH: 4.74 )
Ranked among companies with meaningful Current Ratio only.
SSH' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 11.77 Max: 63.13
Current: 4.74
1.06
63.13
Quick Ratio 4.74
SSH's Quick Ratio is ranked higher than
80% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SSH: 4.74 )
Ranked among companies with meaningful Quick Ratio only.
SSH' s Quick Ratio Range Over the Past 10 Years
Min: 1.06  Med: 11.77 Max: 63.13
Current: 4.74
1.06
63.13

Valuation & Return

vs
industry
vs
history
Price/Net Cash 1.08
SSH's Price/Net Cash is ranked higher than
99% of the 147 Companies
in the Global Medical Devices industry.

( Industry Median: 12.41 vs. SSH: 1.08 )
Ranked among companies with meaningful Price/Net Cash only.
SSH' s Price/Net Cash Range Over the Past 10 Years
Min: 2.2  Med: 3.03 Max: 31.61
Current: 1.08
2.2
31.61
Price/Net Current Asset Value 1.03
SSH's Price/Net Current Asset Value is ranked higher than
98% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 6.25 vs. SSH: 1.03 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SSH' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.16  Med: 3.19 Max: 163
Current: 1.03
2.16
163
Price/Tangible Book 0.99
SSH's Price/Tangible Book is ranked higher than
97% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 4.33 vs. SSH: 0.99 )
Ranked among companies with meaningful Price/Tangible Book only.
SSH' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.13  Med: 3.16 Max: 32.6
Current: 0.99
2.13
32.6
Price/Median PS Value 0.29
SSH's Price/Median PS Value is ranked higher than
95% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SSH: 0.29 )
Ranked among companies with meaningful Price/Median PS Value only.
SSH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.65  Med: 1.13 Max: 1.25
Current: 0.29
0.65
1.25
Earnings Yield (Greenblatt) (%) -1496.75
SSH's Earnings Yield (Greenblatt) (%) is ranked lower than
100% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. SSH: -1496.75 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SSH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -18157.96  Med: 0.00 Max: 20414.35
Current: -1496.75
-18157.96
20414.35

More Statistics

Revenue(Mil) $0
EPS $ -1.51
Beta1.35
Short Percentage of Float5.35%
52-Week Range $0.91 - 6.90
Shares Outstanding(Mil)18.34

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 0 2 6 9
EPS($) -1.46 -1.55 -1.55 -1.35
EPS without NRI($) -1.46 -1.55 -1.55 -1.35

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SHC.Australia, 22S.Germany,
Sunshine Heart Inc was incorporated in Delaware on August 22, 2002. The company is an early-stage medical device company engaged in developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. Its C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. It is in the process of obtaining regulatory approvals necessary to sell its product. Combined, these potential benefits may help reverse the heart failure process or maintain the patient's current condition, thereby potentially preventing the need for later-stage heart failure devices, such as LVADs, artificial hearts or transplants. Its competitors include: AbioMed, Inc., Berlin Heart GmbH, CardioKinetix, Inc., CircuLite, Inc. & HeartWare International Inc. Its business is subject to extensive federal and state government regulation.
» More Articles for SSH

Headlines

Articles On GuruFocus.com

More From Other Websites
Sunshine Heart Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Jan 19 2016
Sunshine Heart Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Jan 19 2016
Edited Transcript of SSH earnings conference call or presentation 3-Nov-15 2:00pm GMT Jan 07 2016
Sunshine Heart Appoints Eric Lovett as Vice President, Clinical Affairs Jan 05 2016
Sunshine Heart Appoints Eric Lovett as Vice President, Clinical Affairs Jan 05 2016
SUNSHINE HEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Dec 09 2015
Sunshine Heart Amends Its Debt Agreement with Silicon Valley Bank Dec 09 2015
Sunshine Heart Amends Its Debt Agreement with Silicon Valley Bank Dec 09 2015
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015 Dec 09 2015
Sunshine Heart Announces Departure of Its Chief Executive Officer David A. Rosa Dec 09 2015
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015 Dec 09 2015
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Dec 09 2015
SUNSHINE HEART, INC. Financials Dec 08 2015
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Dec 07 2015
SUNSHINE HEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 30 2015
Sunshine Heart Announces Departure of Its Chief Executive Officer David A. Rosa Nov 30 2015
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015 Nov 25 2015
SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly Report Nov 05 2015
Sunshine Heart Inc Earnings Call scheduled for 9:00 am ET today Nov 03 2015
SUNSHINE HEART, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 03 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK